Search Results - Eric R. Lutz

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Targeting neoantigens to augment antitumour immunity

    Targeting neoantigens to augment antitumour immunity by Mark Yarchoan, Burles A. Johnson, Eric R. Lutz, Daniel A. Laheru, Elizabeth M. Jaffee

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Erratum: Targeting neoantigens to augment antitumour immunity

    Erratum: Targeting neoantigens to augment antitumour immunity by Mark Yarchoan, Burles A. Johnson, Eric R. Lutz, Daniel A. Laheru, Elizabeth M. Jaffee

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

    A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells by Paul E. Zarek, Ching-Tai Huang, Eric R. Lutz, Jeanne Kowalski, Maureen R. Horton, Joel Linden, Charles G. Drake, Jonathan D. Powell

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/<i>neu</i>-Transgenic Mice

    HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cel... by Matthew E. Wolpoe, Eric R. Lutz, Anne M. Ercolini, Satoshi Murata, Susan E. Ivie, Elizabeth S. Garrett, Leisha A. Emens, Elizabeth M. Jaffee, R. Todd Reilly

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma

    T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma by Alexander C. Hopkins, Mark Yarchoan, Jennifer N. Durham, Erik Yusko, Julie Rytlewski, Harlan Robins, Daniel A. Laheru, Dung T. Le, Eric R. Lutz, Elizabeth M. Jaffee

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

    Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients by Amy Thomas, Lynn M. Santarsiero, Eric R. Lutz, Todd D. Armstrong, Yi-Cheng Chen, Lan-Qing Huang, Daniel A. Laheru, Michael Goggins, Ralph H. Hruban, Elizabeth M. Jaffee

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation

    Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study... by Dan Laheru, Eric R. Lutz, James M. Burke, Barbara Biedrzycki, Sara Solt, Beth Onners, Irena Tartakovsky, John Nemunaitis, Dung T. Le, Elizabeth A. Sugar, Kristen Hege, Elizabeth M. Jaffee

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

    Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer by Dung T. Le, Eric R. Lutz, Jennifer N. Uram, Elizabeth A. Sugar, Beth Onners, Sara Solt, Lei Zheng, Luis A. Díaz, Ross C. Donehower, Elizabeth M. Jaffee, Daniel A. Laheru

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    OX40 Costimulation Synergizes with GM-CSF Whole-Cell Vaccination to Overcome Established CD8+ T Cell Tolerance to an Endogenous Tumor Antigen

    OX40 Costimulation Synergizes with GM-CSF Whole-Cell Vaccination to Overcome Established CD8+ T Cell Tolerance to an Endogenous Tumor Antigen by Satoshi Murata, Brian H. Ladle, Peter Kim, Eric R. Lutz, Matthew E. Wolpoe, Susan E. Ivie, Holly Smith, Todd D. Armstrong, Leisha A. Emens, Elizabeth M. Jaffee, R. Todd Reilly

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

    Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer by Heather Kinkead, Alexander C. Hopkins, Eric R. Lutz, Annie A. Wu, Mark Yarchoan, Kayla Cruz, Skylar Woolman, Teena Vithayathil, Laura Hix Glickman, Chudi Ndubaku, Sarah M. McWhirter, Thomas W. Dubensky, Todd D. Armstrong, Elizabeth M. Jaffee, Neeha Zaidi

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

    Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation by Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin C. Soares, Sara Solt, Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel A. Laheru, Christopher L. Wolfgang, Jiang Wang, Ralph H. Hruban, Robert A. Anders, Elizabeth M. Jaffee, Lei Zheng

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors

    PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors by Kevin C. Soares, Agnieszka A. Rucki, Annie A. Wu, Kelly Olino, Qian Xiao, Yi Chai, Anthony Wamwea, Elaine Bigelow, Eric R. Lutz, Linda Liu, Sheng Yao, Robert A. Anders, Daniel A. Laheru, Christopher L. Wolfgang, Barish H. Edil, Richard D. Schulick, Elizabeth M. Jaffee, Lei Zheng

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

    Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis by Takahiro Tsujikawa, Sushil Kumar, Rohan N. Borkar, Vahid Azimi, Guillaume Thibault, Young Hwan Chang, Ariel Balter, Rie Kawashima, Gina Choe, David Sauer, Edward El Rassi, Daniel Clayburgh, Molly Kulesz‐Martin, Eric R. Lutz, Lei Zheng, Elizabeth M. Jaffee, Patrick Leyshock, Jake Lin, Motomi Mori, Joe W. Gray, Paul W. Flint, Lisa M. Coussens

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

    A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induc... by Dung T. Le, Dirk G. Brockstedt, Ran Nir‐Paz, Johannes Hampl, Shruti Mathur, John Nemunaitis, Daniel H. Sterman, Raffit Hassan, Eric R. Lutz, Bentley Moyer, Martin Giedlin, Jana-Lynn Louis, Elizabeth A. Sugar, Alice Pons, Andrea L. Cox, Jordana Levine, Aimee Murphy, Peter B. Illei, Thomas W. Dubensky, Joseph E. Eiden, Elizabeth M. Jaffee, Daniel A. Laheru

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

    Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer by Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: